Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Poland

European Innovation Council · Running

in silico bio-evolutio in silico bio-evolutio - novel AI paradigm for molecular biology

Coordinator
Camino Science Sp. Z O.o., Poland
Runs
1 January 2023 to 31 May 2025
Status
Running
EU funding
€1.7m
Total cost
€2.4m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190103838

What the project is doing

In the project's own words, from its summary on CORDIS.

The success of phage therapies relies on correctly matching a therapeutic phage to bacterial strain. However calibration of therapy recipe may last for years. Presented solution enable to accelerate this by in silico simulations on AI platform for in vitro. It is able to find optimal phage that meets the phenotype imposed by the researcher, especially: -predict given phage effectiveness against a specific bacteria strain,-indicate mutations that increase phage effectiveness,-generate explanations for predictions.

Currently, this process is performed by wet-lab employees (in vitro). Replacing it with an in silico process will reduce the number 90 out of 100 experiments, significantly accelerating the process and improving phage therapy quality. At the same time, its the basis for modern probiotics (for microbiome modulation). At the same time, it will enable dynamically generate personalized therapies for specific patients. It is a novel endeavor in the area of molecular biology.

Topics

Who is involved

OrganisationCityCountryRole
Camino Science Sp. Z O.o.BiaystokPolandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI